胸腺切除术治疗抗NMDA受体脑炎
本病例报告介绍一名25岁女性,诊断为抗N-甲基-D-天冬氨酸(NMDA)受体脑炎后发现胸腺增生,接受机器人双侧入路胸腺切除术治疗,术后未用药保持无症状。这是第二例报道胸腺切除术治疗该病的病例,提示胸腺组织可能参与抗NMDA受体脑炎发病,胸腺切除术对该病部分患者是合适治疗。
要点
- 25岁女性抗NMDA受体脑炎合并胸腺增生,行机器人双侧入路胸腺切除术。
- 术后未用药保持无症状。
- 为第二例报道胸腺切除术治疗该病的病例。
核心结论
- 本病例进一步提示胸腺组织参与抗NMDA受体脑炎的发生,胸腺切除术对该病部分患者是合适的治疗。
研究设计与样本
- 病例报告,报道一例25岁女性抗NMDA受体脑炎合并胸腺增生患者。
主要发现
- 患者接受机器人双侧入路胸腺切除术治疗抗NMDA受体脑炎,术后未用药保持无症状。
- 这是第二例报道胸腺切除术治疗该病的病例。
临床怎么用
- 作者认为胸腺切除术可能是该病部分患者的合适治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this case report, we present a 25-year-old woman who was diagnosed with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis and subsequently was found to have thymic hyperplasia. She underwent robotic bilateral access thymectomy for treatment of her anti-NMDA receptor encephalitis and has remained asymptomatic after her operation without any medication. This is only the second reported case of thymectomy for treatment of this condition. This case may further suggest thymic tissue is involved in the development of anti-NMDA receptor encephalitis and that thymectomy is an appropriate treatment for a subset of patients with this disease.
引用
- Palleiko BA, Salamatbad G, Bludevich BM, et al. Thymectomy for treatment of anti-NMDA receptor encephalitis. Eur J Cardiothorac Surg. 2022. PMID: 35640994. doi:10.1093/ejcts/ezac329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。